COVID-19 Deaths of Despair; Gun Suicide Risk Factors

— News and commentary from the psychiatry world

MedicalToday
Illustration of a brain shaped maze.

Up to from drug, alcohol abuse, and suicide could stem from the COVID-19 pandemic. (CBS News)

The phase IIIb ALPINE study found that a 2-month formulation of with 1-day initiation during hospitalization for people with schizophrenia was both safe and effective. (The Journal of Clinical Psychiatry)

A large study found that kids with -- including fasting, purging, prolonged dieting, and binge-eating -- at a much higher rate. (U.S. News & World Report)

Among gun owners, risk of was highest for white men in states with high firearm ownership, those in rural areas, and military personnel. (JAMA Internal Medicine)

Not surprisingly, mental distress exhibited a dose-response relationship with . (BMJ Open)

A research team at Stony Brook University in New York won a 5-year $3.5-million NIH grant for a .

VistaGen Therapeutics announced it submitted a proposed protocol to the FDA for a , an investigational anti-anxiety drug for adjustment disorder related to the COVID-19 pandemic.

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.